arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

AtaiBeckley Inc.

ATAI
$7.36 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
6 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

AtaiBeckley Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.7B
Dividend Yield —
Revenue Growth 137.0% ↗
Op. Margin —
ROIC -25.1% ↘
FCF / Share $-0.10 ↘
Trailing P/E —
Price / Book 15.4x
FCF Yield —
Debt / Equity 0.13
info Valuation on last close. End-of-day price, Sep 10, 2026.

6-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.70M
↑ +137.0% —
Net Income Profit after all expenses
$-32.52M
↓ -17.3% —
FCF / Share Free cash flow per share
$-0.10
↓ -35.1% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
0
Financial Health →
25
Cash Quality ↓
28

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 2 years · 6 quarters